Clinical Trial Update: Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating autologous stem cell transplantation in patients with recurrent nasopharyngeal carcinoma; study terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: University of Florida | Conditions: Recurrent Nasopharynx Carcinoma | Phase 3 | Status: TERMINATED | Results posted: 2019-06-24